News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
89,291 Results
Type
Article (3401)
Company Profile (16)
Press Release (85874)
Section
Business (35192)
Career Advice (79)
Deals (7366)
Drug Delivery (11)
Drug Development (11529)
Employer Resources (11)
FDA (2131)
Job Trends (2385)
News (54255)
Policy (3545)
Tag
Academia (210)
Accelerated approval (1)
Allergies (15)
Alliances (3884)
ALS (10)
Alzheimer's disease (206)
Antibody-drug conjugate (ADC) (16)
Approvals (2173)
Artificial intelligence (19)
Autoimmune disease (2)
Automation (1)
Bankruptcy (41)
Best Places to Work (2096)
BIOSECURE Act (2)
Biosimilars (4)
Biotechnology (13)
Bladder cancer (28)
Brain cancer (3)
Breast cancer (57)
Cancer (391)
Cardiovascular disease (28)
Career advice (71)
CAR-T (16)
Cell therapy (58)
Cervical cancer (1)
Clinical research (10234)
Collaboration (71)
Compensation (104)
Complete response letters (1)
COVID-19 (323)
CRISPR (10)
C-suite (17)
Cystic fibrosis (7)
Data (489)
Depression (2)
Diabetes (46)
Diagnostics (1025)
Digital health (2)
Diversity (1)
Diversity, equity & inclusion (2)
Drug discovery (7)
Drug pricing (9)
Drug shortages (4)
Duchenne muscular dystrophy (8)
Earnings (28600)
Editorial (1)
Employer branding (1)
Employer resources (10)
Events (9236)
Executive appointments (34)
FDA (2412)
Frontotemporal dementia (2)
Funding (107)
Gene editing (18)
Generative AI (2)
Gene therapy (36)
GLP-1 (107)
Government (488)
Grass and pollen (2)
Guidances (98)
Healthcare (2773)
Huntington's disease (3)
IgA nephropathy (5)
Immunology and inflammation (15)
Indications (4)
Infectious disease (361)
Inflammatory bowel disease (12)
Influenza (14)
Intellectual property (10)
Interviews (3)
IPO (5080)
IRA (2)
Job creations (397)
Job search strategy (65)
Kidney cancer (1)
Labor market (5)
Layoffs (58)
Legal (709)
Liver cancer (12)
Lung cancer (60)
Lymphoma (50)
Machine learning (1)
Management (4)
Manufacturing (46)
MASH (17)
Medical device (2133)
Medtech (2133)
Mergers & acquisitions (2389)
Metabolic disorders (112)
Multiple sclerosis (16)
NASH (3)
Neurodegenerative disease (14)
Neuropsychiatric disorders (7)
Neuroscience (290)
NextGen: Class of 2025 (738)
Non-profit (407)
Now hiring (2)
Obesity (51)
Opinion (12)
Ovarian cancer (19)
Pain (17)
Pancreatic cancer (5)
Parkinson's disease (20)
Partnered (4)
Patents (16)
Patient recruitment (15)
Peanut (7)
People (3037)
Pharmaceutical (4)
Pharmacy benefit managers (1)
Phase I (2393)
Phase II (4330)
Phase III (4329)
Pipeline (577)
Policy (8)
Postmarket research (388)
Preclinical (621)
Press Release (1)
Prostate cancer (11)
Psychedelics (7)
Radiopharmaceuticals (27)
Rare diseases (44)
Real estate (489)
Recruiting (4)
Regulatory (2641)
Reports (5)
Research institute (248)
Resumes & cover letters (10)
RSV (24)
Schizophrenia (23)
Series A (14)
Series B (12)
Service/supplier (1)
Sickle cell disease (6)
Special edition (3)
Spinal muscular atrophy (43)
Sponsored (2)
Startups (313)
Stomach cancer (3)
Supply chain (7)
Tariffs (5)
The Weekly (2)
Vaccines (94)
Venture capitalists (4)
Weight loss (35)
Women's health (3)
Date
Today (72)
Last 7 days (267)
Last 30 days (563)
Last 365 days (5733)
2025 (2007)
2024 (6356)
2023 (7430)
2022 (8781)
2021 (9252)
2020 (8629)
2019 (6303)
2018 (4686)
2017 (4377)
2016 (3603)
2015 (4632)
2014 (2960)
2013 (1917)
2012 (2236)
2011 (2566)
2010 (2398)
Location
Africa (59)
Alabama (9)
Alaska (1)
Arizona (28)
Arkansas (2)
Asia (5183)
Australia (805)
California (1042)
Canada (338)
China (65)
Colorado (49)
Connecticut (48)
Delaware (43)
Europe (13580)
Florida (182)
Georgia (38)
Idaho (1)
Illinois (70)
India (1)
Indiana (64)
Iowa (1)
Japan (36)
Kansas (19)
Kentucky (2)
Louisiana (4)
Maine (32)
Maryland (110)
Massachusetts (880)
Michigan (38)
Minnesota (59)
Missouri (6)
Montana (4)
Nebraska (1)
Nevada (12)
New Hampshire (9)
New Jersey (391)
New Mexico (2)
New York (309)
North Carolina (141)
Northern California (503)
Ohio (38)
Oregon (4)
Pennsylvania (240)
Puerto Rico (1)
Rhode Island (1)
South America (111)
South Carolina (1)
Southern California (405)
Tennessee (7)
Texas (155)
United States (4088)
Utah (29)
Virginia (19)
Washington D.C. (3)
Washington State (93)
Wisconsin (3)
89,291 Results for "75".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Verastem Oncology Announces $75 million Private Placement
April 28, 2025
·
4 min read
Press Releases
Theriva Biologics Announces Pricing of $7.5 Million Public Offering
May 7, 2025
·
5 min read
Press Releases
Adial Pharmaceuticals Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds
May 2, 2025
·
6 min read
Press Releases
Positive Outcome in 75% of CTCL Patients Treated with HyBryte™ for 18 Weeks
April 15, 2025
·
18 min read
Press Releases
ImmunityBio Announces Execution of $75 Million Equity Financing with an Institutional Investor
April 8, 2025
·
5 min read
Layoffs
Repare Therapeutics to Cut Staff Again, This Time by 75%
The latest Repare Therapeutics layoffs will include its chief medical officer and could leave the biotech with fewer than 35 employees as it works to advance two Phase I clinical programs.
February 25, 2025
·
2 min read
·
Angela Gabriel
Press Releases
Shuttle Pharma Announces Closing of $5.75 Million Underwritten Offering
March 14, 2025
·
4 min read
Press Releases
Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering
March 13, 2025
·
4 min read
Press Releases
NYU Langone Heart Cardiologists Present at ACC’s 75th Annual Scientific Session
March 28, 2025
·
6 min read
Press Releases
Kuros Biosciences grows sales to CHF 75.6 million for 2024
March 11, 2025
·
10 min read
1 of 8,930
Next
